Antonio S. Montecalvo's most recent trade in Organogenesis Holdings Inc - Ordinary Shares - Class A was a trade of 43,956 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 43,956 | 43,956 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 42,493 | 196,680 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 8,657 | 156,158 (0%) | 0% | 3.7 | 32,031 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 3,453 | 164,815 (0%) | 0% | 3.7 | 12,776 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 1,252 | 154,906 (0%) | 0% | 3.7 | 4,632 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Feb 2025 | 719 | 154,187 (0%) | 0% | 3.7 | 2,660 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 01 Apr 2024 | 1,752 | 168,268 (0%) | 0% | 2.8 | 4,906 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 79,068 | 79,068 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Montecalvo S. Antonio | Vice President, Health Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 43,732 | 170,020 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 15 Feb 2024 | 8,657 | 128,259 (0%) | 0% | 3.7 | 31,858 | Class A Common Stock |
| Organogenesis Holdings Inc... | S. Montecalvo Antonio | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.68 per share. | 15 Feb 2024 | 1,252 | 127,007 (0%) | 0% | 3.7 | 4,607 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.48 per share. | 15 Feb 2024 | 719 | 126,288 (0%) | 0% | 3.5 | 2,502 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 01 Apr 2023 | 2,097 | 136,916 (0%) | 0% | 2.1 | 4,467 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 118,035 | 118,035 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 99,428 | 139,013 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | VP Health Policy & Contracting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.92 per share. | 15 Feb 2023 | 1,249 | 40,302 (0%) | 0% | 2.9 | 3,647 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | VP Health Policy & Contracting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 Feb 2023 | 717 | 39,585 (0%) | 0% | 2.8 | 1,972 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | Vice President, Health Policy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.89 per share. | 01 Apr 2022 | 2,738 | 41,551 (0%) | 0% | 7.9 | 21,603 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | VP Health Policy & Contracting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 34,112 | 34,112 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | VP Health Policy & Contracting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 14,383 | 83,939 (0%) | 0% | 0 | Class A Common Stock | |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | VP Health Policy & Contracting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.78 per share. | 15 Feb 2022 | 718 | 83,221 (0%) | 0% | 7.8 | 5,586 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | VP Health Policy & Contracting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.83 per share. | 01 Apr 2021 | 1,770 | 69,556 (0%) | 0% | 19.8 | 35,099 | Class A Common Stock |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | VP Health Policy & Contracting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 63,246 | 63,246 | - | - | Stock Option (Right to Buy) | |
| Organogenesis Holdings Inc... | Antonio S. Montecalvo | VP Health Policy & Contracting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 8,260 | 71,326 (0%) | 0% | 0 | Class A Common Stock |